BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bowlus CL, Lim JK, Lindor KD. AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.Clin Gastroenterol Hepatol. 2019;17:2416-2422. [PMID: 31306801 DOI: 10.1016/j.cgh.2019.07.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Carbone M, Baiocchi L. Management of cholangiocarcinoma in the third millennium: time to be guided! Dig Liver Dis 2020;52:1428-9. [PMID: 33248542 DOI: 10.1016/j.dld.2020.11.003] [Reference Citation Analysis]
2 Rabiee A, Silveira MG. Primary sclerosing cholangitis. Transl Gastroenterol Hepatol 2021;6:29. [PMID: 33824933 DOI: 10.21037/tgh-20-266] [Reference Citation Analysis]
3 Eaton JE, Welle CL, Bakhshi Z, Sheedy SP, Idilman IS, Gores GJ, Rosen CB, Heimbach JK, Taner T, Harnois DM, Lindor KD, LaRusso NF, Gossard AA, Lazaridis KN, Venkatesh SK. Early Cholangiocarcinoma Detection With Magnetic Resonance Imaging Versus Ultrasound in Primary Sclerosing Cholangitis. Hepatology 2021;73:1868-81. [PMID: 32974892 DOI: 10.1002/hep.31575] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
4 Vlăduţ C, Ciocîrlan M, Bilous D, Șandru V, Stan-Ilie M, Panic N, Becheanu G, Jinga M, Costache RS, Costache DO, Diculescu M. An Overview on Primary Sclerosing Cholangitis. J Clin Med 2020;9:E754. [PMID: 32168787 DOI: 10.3390/jcm9030754] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Bosch DE, Zen Y, Boukhar SA, Liu Y, Cheng L, Yeh MM. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting. Virchows Arch 2021. [PMID: 34414507 DOI: 10.1007/s00428-021-03183-6] [Reference Citation Analysis]
6 Nicoletti A, Maurice JB, Thorburn D. Guideline review: British Society of Gastroenterology/UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Frontline Gastroenterol 2021;12:62-6. [PMID: 33456743 DOI: 10.1136/flgastro-2019-101343] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Daiku K, Fukuda K, Morimoto O, Takiuchi D, Shimakoshi H, Kegasawa T, Yamaguchi Y, Kogita S, Sawai Y, Nakahara M, Igura T, Shibata K, Imai Y. Primary adenosquamous carcinoma of the liver detected during cancer surveillance in a patient with primary sclerosing cholangitis. Clin J Gastroenterol 2020;13:1273-9. [PMID: 32785892 DOI: 10.1007/s12328-020-01204-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Hawken J, Appanna G, Portal AJ. Is it time for recommendations to reflect reality in PSC surveillance? Frontline Gastroenterol 2022;13:88-9. [PMID: 34970432 DOI: 10.1136/flgastro-2021-101812] [Reference Citation Analysis]
9 Vesterhus M, Karlsen TH. Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities. J Gastroenterol 2020;55:588-614. [PMID: 32222826 DOI: 10.1007/s00535-020-01681-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
10 Saffioti F, Mavroeidis VK. Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis. World J Gastrointest Oncol 2021; 13(10): 1336-1366 [PMID: 34721770 DOI: 10.4251/wjgo.v13.i10.1336] [Reference Citation Analysis]
11 Venkatesh SK, Welle CL, Miller FH, Jhaveri K, Ringe KI, Eaton JE, Bungay H, Arrivé L, Ba-Ssalamah A, Grigoriadis A, Schramm C, Fulcher AS. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group. Eur Radiol 2021. [PMID: 34363134 DOI: 10.1007/s00330-021-08147-7] [Reference Citation Analysis]
12 Fung BM, Tabibian JH. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices. Expert Rev Gastroenterol Hepatol 2021;15:487-96. [PMID: 33682586 DOI: 10.1080/17474124.2021.1900732] [Reference Citation Analysis]
13 Barner-Rasmussen N, Pukkala E, Hadkhale K, Färkkilä M. Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland. United European Gastroenterol J 2021. [PMID: 34533900 DOI: 10.1002/ueg2.12154] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chung HG, Chang JI, Lee KH, Park JK, Lee KT, Lee JK. Comparison of EUS and ERCP-guided tissue sampling in suspected biliary stricture. PLoS One 2021;16:e0258887. [PMID: 34669743 DOI: 10.1371/journal.pone.0258887] [Reference Citation Analysis]
15 Prokopič M, Beuers U. Management of primary sclerosing cholangitis and its complications: an algorithmic approach. Hepatol Int 2021;15:6-20. [PMID: 33377990 DOI: 10.1007/s12072-020-10118-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]